NCT06898424Completed
Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression
Effects of Concurrent Plant-Based Ketogenic Diet and Intermittent Fasting (Ketoflex 12/3) on the Clinical Progression of Early-to-Mid Stage Alzheimer's Dementia
Source: ClinicalTrials.gov · Last updated 24 Mar 2026
Brief summary (registry, in English)
This study investigates the effects of the Ketoflex 12/3 diet on the clinical progression of early-to-mid stage Alzheimer's disease. The study evaluates cognitive function, metabolic changes, and overall health outcomes in participants following the Ketoflex 12/3 dietary protocol.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 20 Mar 2025
- Start date
- 1 Mar 2024
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Prof. Lutfu Hanoglu, MD
- Diseases
- Alzheimer disease
- NCT number
- NCT06898424
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Mar 2024 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of chronic renal failure
- Diagnosis of another neuropsychiatric disorder
- Presence of amalgam dental fillings and/or failure to have them removed following the SMART protocol
Other
- Alcohol and/or substance dependence
Who the study is looking for
- Age between 50-85 years
- Clinical Dementia Rating (CDR) score of 1 or2
- Diagnosis of Alzheimer's disease (AD) according to NIA-AA criteria
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Medipol Universitesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
Related publications
- The effect of simultaneous application of plant-rich ketogenic diet and intermittent fasting on early-to-mid-stage Alzheimer's disease: a randomised controlled trial.J Nutr Health Aging · 2026 · PMID 42497811
This page is information, not medical advice. Discuss any trial with your doctor.